Annovis Bio (ANVS) Total Non-Current Liabilities (2019 - 2026)
Annovis Bio (ANVS) posted Total Non-Current Liabilities of $6.36 million for Q2 2026, up 126.7% from $2.81 million a year earlier but down 50.3% from the prior quarter.
Powered by 
Analysis
Annovis Bio (ANVS) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
At the end of FY2025, Annovis Bio's Total Non-Current Liabilities came in at $3.64 million, down 6.3% from FY2024.
- In prior years, Annovis Bio's Total Non-Current Liabilities was $3.88 million in FY2024 (-9.3%) and $4.28 million in FY2023.
- Quarterly Total Non-Current Liabilities has run from a low of $2.5 million in Q1 2025 to a high of $12.79 million in Q1 2026 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in two of the last seven quarters, with growth averaging 57.0%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $12.79 million (Q1 2026), $3.64 million (Q4 2025) and $3.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Annovis Bio | 58.80 Mn | 58.80 Mn | - | 6.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.36 Mn |
| Mar 31, 2026 | 12.79 Mn |
| Dec 31, 2025 | 3.64 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 2.81 Mn |
| Mar 31, 2025 | 2.50 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | 5.83 Mn |
| Jun 30, 2024 | 4.56 Mn |
| Mar 31, 2024 | 4.87 Mn |
| Dec 31, 2023 | 4.28 Mn |
| Dec 31, 2019 | 605,807.00 |
API Access
Annovis Bio Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ANVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();